Substance Abuse
Conditions
Keywords
Drug treatment entry and retention, Drug injection frequency, HIV risk behaviors, Hepatitis C risk behaviors
Brief summary
This is a five-year prospective randomized trial comparing two intervention conditions designed to facilitate substance abuse treatment entry and enhance retention in order to reduce the behaviors associated with HIV and HCV risk among injection drug users (IDUs) and to improve client overall functioning. The overall goal of this project is to compare strengths-based case-management (CM) to an enhanced version of CM that uses case managers to facilitate a therapeutic alliance (CM/FTA) among out-of-treatment IDUs in Denver.
Interventions
BEHAVIORALStrengths-based case management
Clients will receive counseling and/or referrals for help with nine life domains (life skills, finances, leisure activities, relationships, living arrangements, occupation/education, health, mental health, recovery from substances, legal assistance) for a period of five months after baseline.
BEHAVIORALCase management plus facilitated treatment alliance
Clients will receive counseling and/or referrals for help with nine life domains (life skills, finances, leisure activities, relationships, living arrangements, occupation/education, health, mental health, recovery from substances, legal assistance) for a period of five months after baseline. They will also receive a facilitated treatment alliance, which consists of meetings with methadone counselors to aid in treatment entry.
Sponsors
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
University of Colorado, Denver
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* opiate injection at least 3 times a week during the last 6-months * 18 years of age or older * no drug abuse treatment in the 30-days prior to the interview * not transient * no known reason (e.g. pending jail time) why they will not be available for follow-up interviews * not involved in Project Safe research activities in the previous 12 months * willing to meet with an Addiction Research and Treatment Services (methadone clinic) counselor * eligible to be treated at ARTS
Exclusion criteria
* too intoxicated or impaired mentally to voluntarily consent to participate in the project and/or respond to the interview
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatment entry and retention | Baseline, 6 months after baseline, 12 months after baseline |
Secondary
| Measure | Time frame |
|---|---|
| Drug injection and HIV/HCV risk behaviors | Baseline, 6 months after baseline, 12 months after baseline |
Countries
United States
Outcome results
None listed